Adjuvant therapy for meningococcal sepsis

Pediatric Infectious Disease Journal

Volumn 24, Issue 2, 2005, Pages 177-178

  Fischer, Marc ^a   Hilinski, Joseph ^b   Stephens, David S ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Meningococcal sepsis

Indexed keywords

ALTEPLASE; ANTITHROMBIN III; CORTICOSTEROID; DROTRECOGIN; E 5531; ENDOTOXIN; FIBRINOLYTIC AGENT; HEPARIN; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M MONOCLONAL ANTIBODY BINDING PROTEIN; INSULIN; PLACEBO; RECOMBINANT BACTERICIDAL PERMEABILITY INCREASING PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SERINE PROTEINASE INHIBITOR; STEROID; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; BLEEDING TENDENCY; BLOOD TRANSFUSION; BRAIN HEMANGIOMA; CELL MIGRATION; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG DOSE REGIMEN; DRUG RECEPTOR BINDING; HEMOFILTRATION; HUMAN; IN VITRO STUDY; MENINGOCOCCEMIA; MORTALITY; NEUTROPHIL; PEDIATRICS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOTOXINS; FLUID THERAPY; HUMANS; MENINGOCOCCAL INFECTIONS; SEPSIS;

EID: 13844281749     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000154437.79398.ed     Document Type: Review

References (15)

1. van Deuren M, et al. Update on meningococcal disease with emphasis on .... Clin Microbiol Rev. 2000;13:144-166.
2. Derkx B, et al. Randomized placebo-controlled trial of HA-1A.... Clin Infect Dis. 1999;28:770-777.
3. Giroir BP, et al. Bactericidal/permeability-increasing protein.... Crit Care Med. 2001;29:8130-8135.
4. Carrol ED, et al. New therapies and vaccines for meningococcal disease. Expert Opin Investig Drugs. 2001;10:1487-1500.
5. Cronin L, et al. Corticosteroid treatment for sepsis: .... Crit Care Med. 1995;23:1430-1439.
6. Lefering R, et al. Steroid controversy in sepsis and septic shock: .... Crit Care Med. 1995;23:1294-1303.
7. Annane D, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone. . .. JAMA. 2002;288:862-871.
8. Dellinger RP, et al. Surviving Sepsis Campaign guidelines for.... Crit Care Med. 2004;32:858-873.
9. McMaster P, et al. The use of extracorporeal techniques.... Pediatr Crit Care Med. 2003;4:2-7.
10. Alberio L, et al. Protein C replacement in severe meningococcemia: . . .. Clin Infect Dis. 2001;32:1338-1346.
11. Bernard GR, et al. Efficacy and safety of recombinant human activated protein C.... N Engl J Med. 2001;344:699-709.
12. Rice TW, et al. Advances in sepsis treatment. Curr Infect Dis Rep. 2004;6:354-360.
13. Giroir BP. Recombinant human activated protein C for the treatment of severe sepsis: . . .? Curr Opin Pediatr. 2003;15:92-96.
14. Zenz W, et al. Use of recombinant tissue plasminogen activator in children with.... Crit Care Med. 2004;32:1777-1780.
15. Van den Berghe G, et al. Intensive insulin therapy.... N Engl J Med. 2001;345:1359-1367.